Not Signed In - Phase II Trial Of Interferon In Combination With Thalidomide For Metastatic Renal Cell Carcinoma
Wed, 22 Nov 2006 08:00 AM EST
... UroToday.com - Both thalidomide and a-interferon (IFN) have been utilized as monotherapy in the treatment of patients with metastatic renal cell carcinoma (RCC), each with modest evidence of activity and acceptable toxicity profiles. One can only wonder as to the relevance of these agents as treatment options, in the era of targeted therapy for patients with metastatic RCC. [click link for full article] ...
Related Topics
- Clinical Trials
- Skin Cancer
- Thalidomide
- Renal Cell Cancer
- Renal cell carcinoma
- Kidney Cancer
- Ribavirin and Interferon alfa-2b, recombinant
- Metastatic Cancer
- Liver Cancer
- Small Cell Lung Cancer
- Merkel Cell Carcinoma
- Renal Cell (Kidney) Cancer
- Kidney (Renal Cell) Cancer
- Islet Cell Carcinoma
- Islet Cell Carcinoma (Pancreatic)
- Skin Carcinoma, Merkel Cell
- Squamous Cell Carcinoma, see Skin Cancer
- Islet Cell Carcinoma (Endocrine Pancreas)
- Basal Cell Carcinoma, see Skin Cancer
- Brain Cancer
email this page
print this page
bookmark this page
feedback on this page
